Literature DB >> 16217081

Age, dose, and environmental temperature are risk factors for topiramate-related hyperthermia.

El Khoury Ziad1, Amal C Rahi, Sahar Abu Hamdan, Mohamad A Mikati.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16217081     DOI: 10.1212/01.wnl.0000179004.97114.97

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  7 in total

1.  Oligohydrosis underestimated side effect with topiramate treatment.

Authors:  Eva L W Fung; Edmund A S Nelson
Journal:  Indian J Pediatr       Date:  2007-07       Impact factor: 1.967

2.  Connective tissue disease following hepatitis B vaccination; topiramate-associated fatal heat stroke; ramelteon-induced autoimmune hepatitis; acute oxaliplatin-induced thrombotic thrombocytopenic purpura.

Authors:  Michael A Mancano
Journal:  Hosp Pharm       Date:  2014-03

Review 3.  The safety and tolerability of newer antiepileptic drugs in children and adolescents.

Authors:  Dean P Sarco; Blaise F D Bourgeois
Journal:  CNS Drugs       Date:  2010-05       Impact factor: 5.749

4.  Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference.

Authors:  Steffen Naegel; Mark Obermann
Journal:  Neuropsychiatr Dis Treat       Date:  2010-02-03       Impact factor: 2.570

5.  Prophylaxis of migraine: general principles and patient acceptance.

Authors:  Domenico D'Amico; Stewart J Tepper
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

6.  Topiramate-induced severe heatstroke in an adult patient: a case report.

Authors:  Lucie Canel; Sofia Zisimopoulou; Marie Besson; Mathieu Nendaz
Journal:  J Med Case Rep       Date:  2016-04-13

7.  Warm Season and Emergency Department Visits to U.S. Children's Hospitals.

Authors:  Aaron S Bernstein; Shengzhi Sun; Kate R Weinberger; Keith R Spangler; Perry E Sheffield; Gregory A Wellenius
Journal:  Environ Health Perspect       Date:  2022-01-19       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.